About ERN LUNG
Expertise
patients
clinicians
ERN-LUNG Academy

The ERN-LUNG Academy is a curriculum for medical staff at any stage of their career, who wishes to get a proof of knowledge on rare respiratory diseases. It consists of Webinars and eCases, but also includes on-site training in ERN-LUNG Centers. We call for applications from participants of EU-member States from September to November each year. Classes start in January. If you wish to apply for next year’s class, please send a letter of motivation to info@ern-lung.eu

ERN-LUNG Online advance system

The EXpert Advisory BOard (EXABO) is a pan-European internet platform, which has been developed in the context of ERN-LUNG in liaison with the Medical Informatics Group of University Hospital Frankfurt, to answer questions on all aspects of rare respiratory diseases. The platform is primarily aimed at patients and care team members but is openly accessible by anyone who wants to ask a related question.

NETWORK
News

High-Level Meeting on the European Research and Innovation Ecosystem for Rare Diseases

The High-level meeting „HLM rare 2025“ was held in Brussels from 9 to 11 December 2025 and was hosted by the European Reference Networks, MEP Vytenis Andriukaitis, and the Brains for Brain Foundation. The meeting aimed to strengthen a European Innovation and Care Ecosystem for Rare and Complex Diseases, addressing the needs of approximately 30 million people living with a rare disease in Europe.

Each day of the meeting focused on a specific theme. The first day concentrated on research and innovation, highlighting the need to support clinical trials and translational research and to help Europe regain leadership in rare disease science through an ambitious Research and Innovation Union. The second day focused on infrastructure and skills with particular emphasis on strengthening the European Reference Networks, expanding EU capacity, and using tools such as newborn screening, shared data spaces, and artificial intelligence to shorten diagnostic pathways. The third day addressed policy and funding, exploring how these can accelerate the translation of innovation into timely and equitable access to care and treatments across Europe. A key outcome of the meeting was the launch of the Declaration on the European Innovation and Care Ecosystem for Rare and Complex Diseases. This Declaration represents  political and strategic commitment to fundamentally transform the ecosystem by setting out a shared vision, clear strategic priorities, and a roadmap for action. It also forsees the establishment of a Consultative group and the development of a concrete and measurable action plan. In the medium to long term, the Declaration aims to accelerate progress in rare and complex diseases through increased availability of treatments, universal newborn screening and improved diagnostic capabilities. The Declaration contains 8 major priorities that were agreed upon and discussed and which will be the roadmap to the next steps and activities.